Malaria medicines to address drug resistance and support malaria elimination efforts
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Malaria medicines to address drug resistance and support malaria elimination efforts
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume 11, Issue 1, Pages 61-70
Publisher
Informa UK Limited
Online
2017-10-02
DOI
10.1080/17512433.2018.1387773
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emergence of Indigenous Artemisinin-Resistant Plasmodium falciparum in Africa
- (2017) Feng Lu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Pyronaridine-Artesunate for Treatment of Uncomplicated Plasmodium falciparum Malaria in Western Cambodia
- (2016) Rithea Leang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial
- (2016) Bronner P. Gonçalves et al. BMC Medicine
- Efficacy of OZ439 (artefenomel) against earlyPlasmodium falciparumblood-stage malaria infection in healthy volunteers
- (2016) James S. McCarthy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial
- (2016) Issaka Sagara et al. LANCET INFECTIOUS DISEASES
- Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial
- (2016) Aung Pyae Phyo et al. LANCET INFECTIOUS DISEASES
- Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial
- (2016) Alassane Dicko et al. LANCET INFECTIOUS DISEASES
- The Community As the Patient in Malaria-Endemic Areas: Preempting Drug Resistance with Multiple First-Line Therapies
- (2016) Maciej F. Boni et al. PLOS MEDICINE
- The Gametocytocidal Efficacy of Different Single Doses of Primaquine with Dihydroartemisinin-piperaquine in Asymptomatic Parasite Carriers in The Gambia: A Randomized Controlled Trial
- (2016) Joseph Okebe et al. EBioMedicine
- Continued Sensitivity ofPlasmodium falciparumto Artemisinin in Guyana, With Absence of Kelch Propeller Domain Mutant Alleles
- (2016) Reyaud Rahman et al. Open Forum Infectious Diseases
- Antimalarial drug resistance in Africa: key lessons for the future
- (2015) Shannon Takala-Harrison et al. Annals of the New York Academy of Sciences
- Malaria and the Millennium Development Goals
- (2015) Stephen Owens ARCHIVES OF DISEASE IN CHILDHOOD
- Supporting malaria elimination with 21st century antimalarial agent drug discovery
- (2015) Thierry T. Diagana DRUG DISCOVERY TODAY
- Independent Emergence of thePlasmodium falciparumKelch Propeller Domain Mutant Allele C580Y in Guyana
- (2015) Stella M. Chenet et al. JOURNAL OF INFECTIOUS DISEASES
- Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker
- (2015) Kyaw M Tun et al. LANCET INFECTIOUS DISEASES
- An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa
- (2015) Ingrid Chen et al. MALARIA JOURNAL
- Malaria medicines: a glass half full?
- (2015) Timothy N. C. Wells et al. NATURE REVIEWS DRUG DISCOVERY
- A Brief History of Qinghaosu
- (2015) Nicholas J. White et al. TRENDS IN PARASITOLOGY
- Optimum population-level use of artemisinin combination therapies: a modelling study
- (2015) Tran Dang Nguyen et al. Lancet Global Health
- Pharmacokinetic Interactions between Primaquine and Pyronaridine-Artesunate in Healthy Adult Thai Subjects
- (2014) Podjanee Jittamala et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Open-Label Crossover Study of Primaquine and Dihydroartemisinin-Piperaquine Pharmacokinetics in Healthy Adult Thai Subjects
- (2014) Borimas Hanboonkunupakarn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Were medicine quality and pharmaceutical management contributing factors in diminishing artemisinin efficacy in Guyana and Suriname?
- (2014) Victor S Pribluda et al. MALARIA JOURNAL
- Primaquine: the risks and the benefits
- (2014) Elizabeth A Ashley et al. MALARIA JOURNAL
- Evidence of an increased incidence of day 3 parasitaemia in Suriname: an indicator of the emerging resistance of Plasmodium falciparum to artemether
- (2014) Stephen GS Vreden et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- The Origins of Antimalarial-Drug Resistance
- (2014) Randall M. Packard NEW ENGLAND JOURNAL OF MEDICINE
- Spiroindolone KAE609 for Falciparum and Vivax Malaria
- (2014) Nicholas J. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fighting drug-resistant Plasmodium falciparum: the challenge of artemisinin resistance
- (2013) C. Wongsrichanalai et al. CLINICAL MICROBIOLOGY AND INFECTION
- Artemisinin resistance or artemisinin-based combination therapy resistance?
- (2013) Chansuda Wongsrichanalai LANCET INFECTIOUS DISEASES
- Single low-dose primaquine to reduce malaria transmission
- (2013) Richard W Steketee et al. LANCET INFECTIOUS DISEASES
- Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial
- (2013) Alice C Eziefula et al. LANCET INFECTIOUS DISEASES
- Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials
- (2013) Stephan Duparc et al. MALARIA JOURNAL
- Designing the next generation of medicines for malaria control and eradication
- (2013) Jeremy N Burrows et al. MALARIA JOURNAL
- Targeting Plasmodium PI(4)K to eliminate malaria
- (2013) Case W. McNamara et al. NATURE
- A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
- (2013) Frédéric Ariey et al. NATURE
- Antimalarial drug discovery — approaches and progress towards new medicines
- (2013) Erika L. Flannery et al. NATURE REVIEWS MICROBIOLOGY
- From bark to weed: The history of artemisinin
- (2013) C. Faurant Parasite
- Arterolane Maleate Plus Piperaquine Phosphate for Treatment of Uncomplicated Plasmodium falciparum Malaria: A Comparative, Multicenter, Randomized Clinical Trial
- (2012) N. Valecha et al. CLINICAL INFECTIOUS DISEASES
- Imidazolopiperazines: Lead Optimization of the Second-Generation Antimalarial Agents
- (2012) Advait Nagle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Policy options for deploying anti-malarial drugs in endemic countries: a population genetics approach
- (2012) Tiago Antao et al. MALARIA JOURNAL
- Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial
- (2012) Kassoum Kayentao et al. MALARIA JOURNAL
- Pyronaridine–Artesunate versus Mefloquine plus Artesunate for Malaria
- (2012) Ronnatrai Rueangweerayut et al. NEW ENGLAND JOURNAL OF MEDICINE
- Piperaquine Resistance Is Associated with a Copy Number Variation on Chromosome 5 in Drug-PressuredPlasmodium falciparumParasites
- (2011) Richard T. Eastman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Artemisinin: Discovery from the Chinese Herbal Garden
- (2011) Louis H. Miller et al. CELL
- Imidazolopiperazines: Hit to Lead Optimization of New Antimalarial Agents
- (2011) Tao Wu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria
- (2011) S. A. Charman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Research Agenda to Underpin Malaria Eradication
- (2011) Pedro L. Alonso et al. PLOS MEDICINE
- Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial
- (2010) Antoinette K Tshefu et al. LANCET
- Changes in the burden of malaria in sub-Saharan Africa
- (2010) Wendy Prudhomme O'Meara et al. LANCET INFECTIOUS DISEASES
- Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty
- (2010) David L Smith et al. MALARIA JOURNAL
- Artemisinin Resistance inPlasmodium falciparumMalaria
- (2009) Arjen M. Dondorp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fixed‐Dose Pyronaridine‐Artesunate Combination for Treatment of Uncomplicated Falciparum Malaria in Pediatric Patients in Gabon
- (2008) Michael Ramharter et al. JOURNAL OF INFECTIOUS DISEASES
- Evidence of Artemisinin-Resistant Malaria in Western Cambodia
- (2008) Harald Noedl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Benefits of using multiple first-line therapies against malaria
- (2008) M. F. Boni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Qinghaosu (Artemisinin): The Price of Success
- (2008) N. J. White SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started